Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Clinical and genetic characteristics of patients with dentatorubro-pallidoluysian atrophy]

Clinical and genetic study of two families with dentatorubral-pallidoluysian atrophy

[Genetics and Clinical Study of Chinese Kindreds with Dentatorubral Pallidoluysian Atrophy].

Overexpanded CAG repeats in ATN1 cause an Early-Onset Case of Dentatorubral-Pallidoluysian atrophy with novel phenotypes and a literature Review of Chinese patients

The Case Report on Dentatorubral?Pallidoluysian Atrophy

[Genetic and Clinical Analysis in a Parkinson's Disease Family Caused by Expansion of SCA2].

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study

DRPLA gene (atrophin-1) sequence and mRNA expression in human brain.

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Research on the normal range of CAG repeats of dentatorubropallidoluysian atrophy gene in Han population of South China mainland

LRP10 in Autosomal-Dominant Parkinson's Disease.

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

Novel GCH1 mutation and clinical study Chinese patients with dopa-responsive dystonia

Early-Onset Parkinson's Disease Caused by PLA2G6 Compound Heterozygous Mutation, a Case Report and Literature Review

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

cDNA cloning and characterization of an atrophin-1 (DRPLA disease gene)-related protein.

Insights into Dentatorubral-Pallidoluysian Atrophy from a new Drosophila model of disease

The Expanding Phenotypic Spectrums Associated with ATP1A3 Mutation in a Family with Rapid-Onset Dystonia Parkinsonism

C-terminal deletion of the atrophin-1 protein results in growth retardation but not neurodegeneration in mice.

Genetic and Clinical Analyses of Spinocerebellar Ataxia Type 8 in Mainland China